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Abstract	A number of fungal pathogens that may result in a variety of human diseases are found in residential
homes and yards. The growth of these microscopic fungi is often favored by particular characteristics
of the dwelling and nearby outdoor environment. Evolved virulence factors or increased ability of
specific fungi to grow in diverse, and sometimes harsh, microenvironments presented by the domestic
environment may promote growth and pathogenesis. Infection may occur by inhalation or direct
inoculation and include endemic fungi in addition to opportunistic or emerging species. Systemic or
locally aggressive fungal infections are particularly likely and may be life-threatening in those with
compromised immune systems. Allergic disease may include sinusitis, pneumonitis and immediate
hypersensitivity. Controversial topics include mycotoxins, volatile organic compounds and sick
building syndrome. This narrative review describes the usual presentations, domestic environmental
sources, prevention techniques and risk of acquiring these diseases in the Midwestern United States.
(J Patient Cent Res Rev. 2016;3:99-110.)
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A number of potential fungal pathogens are found
in residential homes and yards. These microscopic
fungi may result in a variety of human disease. This
includes potentially fatal systemic fungal infections,
traumatic wound infections, allergic manifestations,
exacerbations of asthma, and sometimes vague,
troubling, nonspecific signs and symptoms.
Fortunately, these instances are relatively uncommon;
however, domestically acquired fungal-related disease
in humans may be seen more frequently as the
proportion of immunocompromised patients living at
home increases. Except for dermatophytes, most such
fungal infections were apparently uncommon until
the use of immunosuppressive agents and drugs in the
second half of the 20th century.1,2 No doubt, significant
improvements in the clinical and laboratory diagnosis
of fungal infections in the last several decades has
increased recognition of these diseases.
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Allergic, toxic and irritant diseases from inhaled mold
spores have been known since antiquity.3 The purpose
of this narrative review is to describe disease that may
result from fungal infection or exposure in one’s home
or yard, and to increase clinician awareness that such
illnesses may occur without significant occupational,
recreational or exotic outdoor exposure. Included are
potentially pathogenic fungi found in microenvironments
immediately outside the home as well as on indoor or
outdoor household surfaces, or that are associated with
large appliances or other home furnishings. This article will
not include dermatophyte or fungal infections acquired
through contaminated or colonized food substances or
personal care items, nor will it provide diagnostic or
treatment detail for the diseases discussed. Rather, it is
an overview of the genesis and clinical manifestations of
the more common (e.g. blastomycosis) or emerging (e.g.
black yeasts) types of fungal-related diseases and recent
societal concerns (e.g. sick building syndrome) one might
encounter at home in the Midwestern United States.
Home and Yard Microbial Ecology
Residential Soil and Building Materials: Yards contain
some combination of plants, rocks/concrete/stone,
decaying small animal carcasses and waste, processed
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natural materials such as decorative bark, fencing and, the
principal component, soil. Soil is a mixture of mineral and
organic (humus) constituents. Soil-particle surfaces, pore
spaces and nutrient-rich zones such as the rhizosphere
(soil surrounding a plant root) form particular habitat for
microorganisms, often in biofilms.4-8 The quantity and
types of fungi in a specific soil microenvironment are
determined by a complex interaction of physical attributes
(nutrients, moisture, sunlight, temperature, pH level and
redox potential) and competing organisms (other fungi,
bacteria, archaea, viruses and larger organisms such as
amoebae or worms) (Figure 1).4-9
Factors contributing to the sometimes extreme
environment of residential soil include applied
herbicides, pesticides and other chemicals, temperature
differentials due to the nearby heated dwelling and
radiation of heat from sunlit patios, tannins from new
decorative bark, etc. Concrete or stone are even more
extreme environments for microorganisms. The ability of
fungal pathogens to grow in such diverse environmental
stress may explain their ability to “opportunistically”
inhabit a plethora of challenging niches, including the
human body.10,11 Pathogenic fungi may be indigenous to

the native soil or enter the yard through animal deposits,
manure or purchased materials.9
Home exterior and interior building materials,
surfaces and appliances can be even more extreme
microenvironments for fungi than the surrounding yard.12
Kitchens, bathrooms, metals, hard polymers, silicones,
antiseptics and cleaning products cause oxidative and
other stress on microbial cells. Additionally, indoor
aromatic pollutants may be metabolized by certain
black yeasts. As with residential soil, successful indoor
colonization by a fungus is determined by its ability
to tolerate the particular physiochemical properties of
the building materials or surfaces and derive sufficient
nutrients from them.12 Despite the significant differences
in appearance, indoor surface habitats are often similar
to extreme natural outdoor environments.12 The highmoisture, high-temperature, detergent-laden, alkaline
environment of a household dishwasher is one example.13
The ability to develop so-called “extremotolerance”
may favor genetically and physiologically adaptable
“generalist” fungi such as black yeast12,14 and
Aspergillus spp. (both perhaps ancestrally rock surface
inhabitants)11 as well as Blastomyces spp.15

Figure 1. Microbial

soil ecology. Pictorial
representation of factors
determining distribution
of bacterial and fungal
microorganisms in soil.
Side panels represent
climatic, physical and
geobiochemical factors.
Central panel includes a
magnification (upper circle)
representing soil particles,
pore spaces and bacteria in
biofilm, and another (lower
circle) representing the
rhizosphere and associated
bacteria and fungi (and
amoebae and nematodes).
(Reproduced from
Baumgardner DJ. Soilrelated bacterial and fungal
infections. J Am Board Fam
Med. 2012;25:734-44, by
permission of the American
Board of Family Medicine.)
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Climate Conducive to Fungi: Most environmental
fungi cannot grow at human body temperatures. An
in vitro study of 4,802 fungal strains representing
144 genera revealed that each 1ºC temperature
increase between 30° and 40° restricted the growth
of approximately 6% additional fungal strains.1 In
addition, our complex, redundant immune system
inhibits a majority of potentially pathogenic fungal
species. Again, the ability of a particular organism to
survive our warm-blooded, slightly alkaline internal
environment may be the result of harsh selective factors
in domestic outdoor and indoor environments including
thermal, physical, chemical, oxidative and competitive
stresses.1,2,10,12,14 In addition to thermal tolerance and
biofilms (common among black yeasts and Candida
spp.),12,16 virulence factors for human invasion may have
originated to counterattack bacteria, amoeba, nematodes
and other organisms in the natural environment.1,12 As
Gostinčar and colleagues suggested, “We have made
our indoor (surface) environments prohibitive for the
growth of the majority of microbes. However, the most
resistant ones (and as such possibly the most dangerous)
have succeeded in surviving and adapting.”12
Mold growth and moisture problems are common
in homes. Visible mold may be identified in rooms
whether a problem is suspected or not. It is frequently
found on windowsills, refrigerator seals, spaces
underneath kitchen sinks and air vents. Establishing
normal levels for indoor fungal load has been difficult
and controversial.17 A North Carolina study suggested
that heating, ventilation and air conditioning (HVAC)
systems and associated ductwork may transmit mold
spores from the crawl space to the home interior.18
A recent university housing study from California
examined fungi on residential surfaces including
kitchens and bathroom drains, windowsills and the skin
of human inhabitants. This housing had no reported
mold problems and did not allow pets. The surfaces
yielded a fungal profile similar to that expected in the
outdoor air of that locale, and differed by surface type.
Fungi typical of indoor air, such as Cladosporium
and Cryptococcus, were found on windowsills.
Drains yielded thermotolerant fungi including
Candida, Exophiala and Fusarium. Human forehead
skin contained a variety of indoor- and outdoorassociated fungi.19 In a separate study, fungi, especially
Aspergillus, were identified on home pillows.20
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Other Environmental Factors: Pathogenic fungi may
be introduced into the respiratory tract via bioaerosols
(e.g. wind- or fan-borne spores, dusts and airborne soil
or construction particles). Concentrations of fungal
spores (up to and exceeding 100,000 spores/m3) vary
widely by geographic factors like temperature, moisture,
wind, photoperiod and time of day. Common outdoor
spores include those from Cladosporium, Alternaria,
Penicillium, Aspergillus and others. Indoor spore levels
are generally 40–80% of outdoor levels and reflective
of outdoor species. Humidity, inadequate ventilation
and increased ambient temperature can increase the
fungal burden of a home. A number of indoor sources,
such as plants, pets and mold-transporting footwear and
clothing, also may contribute mold.17,21 Fungal pathogens
can enter humans by traumatic inoculation into wounds.
Simultaneously introduced dirt-related minerals may
promote infection by suppressing local host defenses.6
Much less is known about the contribution to human
disease of fungal toxins and volatile organic compounds
released by fungi.21-24
On occasion, fungal infections may be acquired in
one’s home or yard from a source external to one’s
property, as in the case of an earthquake or dust
storm.25,26 In the Midwest, both histoplasmosis and
blastomycosis apparently have been acquired at home
via airborne spores from a more remote source.27-30
Cases of mucormycosis caused by Apopphysomyces
trapeziformis were reported following a 2011 tornado in
Joplin, Missouri.31
Fungal Infections Primarily Acquired Outdoors
Histoplasmosis: The thermally dimorphic systemic
fungus, Histoplasma capsulatum, is endemic to the
Midwest, where a number of histoplasmosis outbreaks
have occurred.27,32 Evidence of exposure is found in a
majority of residents in this region.33 Histoplasmosis, a
primary pulmonary disease, is often asymptomatic. The
intensity of the acute pneumonia likely correlates with
the burden of inhaled conidia. Pulmonary or mediastinal
masses, nodules, granulomas, fibrosis or pericarditis
may result. Arthralgias or erythema nodosum may
be seen. Acute heavy-inoculum pneumonia may be
severe and require mechanical ventilation. A bilateral,
reticulonodular pattern may be seen on chest X-ray or
computed tomography. The fungus may disseminate in
any pulmonary infection to a variety of organ systems
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(liver, spleen, bone, lymph nodes, central nervous
system, etc.). Patients with underlying lung disease may
experience chronic, progressive (cavitary) pulmonary
histoplasmosis.
H. capsulatum can cause opportunistic infections.27,32,34
Histoplasmosis-associated eye disease, a choroiditis
often associated with serotype HLA-B7, is relatively
unique to the Midwest. Patients are often asymptomatic
unless scarring involves the optic nerve or fovea. A
precise etiologic link to H. capsulatum as the causative
agent is still lacking.32 Pediatric disease is generally
asymptomatic or mild (fever, cough, chest pain and
malaise) and limited to 2 weeks in duration, although
fatigue may linger.32 Localized skin disease following
direct inoculation is rare.30

the former two examples,40,41 environmental testing
was apparently not attempted.
Blastomycosis: Blastomycosis is a potentially lifethreatening systemic and cutaneous fungal infection.43,44
Pulmonary disease is the most common manifestation,
and it has a broad differential diagnosis.45 The pneumonia
may be asymptomatic, chronic or subacute, or sometimes
rapidly progressive with adult respiratory distress
syndrome and death.43 Acute or chronic dissemination
of the fungus to skin, brain, genitourinary system, bones
or virtually any organ system may result.43,45

Growth of H. capsulatum is associated with 67–87%
relative humidity, 90–127 cm of annual precipitation
and mean soil temperatures of 22–29°C.9 The latter may
explain the relative paucity of infections in the most
upper portions of the Midwest. H. capsulatum lives in
soil that is generally moist, acidic and high in nitrogen,
carbohydrate and cationic salt content, particularly
(but not exclusively) in association with bat or bird
guano.27,30 The ability of Histoplasma to assimilate
uric acid and related compounds may explain the latter
association.35 Conidia (spores) are inhaled following
nearby soil disturbance as a result of construction or
excavation or around potted plants.27,36-39 The problem
of birds nesting in large numbers on, in or near
buildings is a particular problem. The large amounts
of guano and nesting materials may remain for years
and pose a health hazard during removal or even fairly
minimal disturbance or dust formation.30

Blastomycosis is caused by Blastomyces dermatitidis
or the newly discovered cryptic species Blastomyces
gilchristii;46 both are dimorphic fungi endemic to the
Midwest. Annual incidence ranges from <1–100 per
100,000 persons. Blastomyces occurs in and near soil
microenvironments. Soil isolations47 and sites of likely
exposure, including home sites, are often associated
with sand soils, nearby waterways and animal excreta.
It also appears to be a survivor of harsh or changing
environmental conditions and may utilize a wide variety
of substrates.48 It is proposed that the ability to grow and
sporulate in carbon-poor, high-ammonia environments
may be a key to its competitive success.15 Preceding
precipitation and environmental temperatures may impact
the occurrence of Blastomyces.49,50 No animal reservoir
has been identified.51 Except for rare inoculation disease
(usually localized to the skin), fungal spores (conidia)
enter the body upon inhalation from the environment
into the lungs. Sources of conidia include wind- or
excavation-generated dusts, disturbance of soil or other
microenvironments and likely moisture-induced natural
spore release from the local environment.28,29,43,52,53

While H. capsulatum spores inhaled from one’s yard
are often generated by a more remote source (often part
of a large urban outbreak),30 there have been specific
instances of exposure from sources on the property.
Examples include infection of homeowners and tenants
during demolition of the exterior walls of an old brick
house that included bird or bat guano,40 infection of
visiting relatives at a family reunion in Iowa exposed
to an old barn,41 and 10 sporadic cases from the same
duplex housing complex on an Air Force base in central
Illinois.42 In the latter cases, several soil sites about the
complex were culture-positive for H. capsulatum. In

While we feel there is good evidence that blastomycosis
may be acquired on one’s own property, and others have
concurred,54 some have disputed this hypothesis.55,56
Evidence includes case studies54,57 and repeated cases
of blastomycosis at the same home site with different
families;58 several studies that failed to implicate
specific outdoor or occupational activities with
acquisition of blastomycosis in most cases;59-61 and the
isolation of B. dermatitidis from an abandoned house62
and 20 m from a human home in northern Wisconsin.47
Evidence, therefore, has been largely circumstantial.
In-home cultures have been otherwise negative,57,58 but
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B. dermatitidis is exceedingly difficult to culture from
the environment.47,57
Sporotrichosis: Sporotrichosis is an uncommon
subacute orchronic mycosis. In normal hosts, it is
primarily a local lymphocutaneous infection resulting
from direct environmental inoculation (thorns,
splinters, cuts, etc.). Days or weeks later, a papule
forms at the site of inoculation, becomes nodular and
may ulcerate. Further nodules typically appear along
the lymphatic distribution of that body site. This
ascending lymphangitis picture also may be caused by
nocardosis, atypical mycobacteria, leishmaniais and
cutaneous anthrax.63 Osteoarticular disease may occur
by direct inoculation or disease extension. Extensive
cutaneous and systemic dissemination often occurs in
untreated patients with underlying disease (alcoholism,
acquired immune deficiency syndrome, diabetes or
chronic obstructive pulmonary disease). Subacute or
chronic pulmonary disease may follow, usually in the
immunocompromised, through dissemination from the
lymphatics or direct inhalation of conidia.63
The etiologic dimorphic fungus Sporothrix schenckii
(and related strains) is found worldwide in soil,
vegetation, sphagnum moss, potting soil, decaying
wood, cornstalks, hay and several warm-blooded
animals. Exposure to infected cats also may result
in disease through scratches, bites or contact with a
lesion on the cat.63-65 Unlike human lesions where the
number of S. schenckii organisms may be low, cat
lesions may have a very high fungal burden that allows
transmission through lesion contact or splash without
penetrating injury.63 Sporotrichosis may be acquired
in the yard or home. A large multistate outbreak took
place in 1988 related to sphagnum moss harvested in
Wisconsin.66 A number of victims were patients who
had received seedlings for their home sites. S. schenckii
was cultured from five samples of unopened moss bales
from one implicated nursery. Another outbreak was
epidemiologically associated with bales of hay from a
Halloween haunted house (there was no residual hay to
culture, and cultures from the implicated fields 5 months
after exposure were negative for S. schenckii).67 Such
bales are often purchased for yard decorations. The
author is personally acquainted with a poorly controlled
diabetic who died of disseminated sporotrichosis
acquired via a thorn puncture from her home garden
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in Illinois. In our own health system’s patient database
(representing several hundred thousand individuals),
there were 15 cases of sporotrichosis diagnosed on
clinical grounds from 2000 to 2009. All but one had
upper extremity disease. Of these 15 suspected cases,
5 had confirmed thorn punctures and 3 had exposure to
other outdoor activity risks.68
Other Mycoses: A variety of nondimorphic, soilrelated yeasts and molds found in residential areas
can cause significant local or systemic human
infection, particularly in the immunocompromised.63,69
Scedosporium apiospermum is an illustrative example
of such a fungus.70 S. apiospermum may cause local,
usually deep, trauma-related infections in normal hosts,
colonization or infection of the respiratory tract in
persons with predisposing conditions, systemic invasive
disease in immunocompromised hosts and pneumonia
or brain abscess in near-drowning or trauma victims.69
Strains of this fungus and the closely related
Pseudallescheria boydii are thermotolerant and have
been associated with agricultural, garden, potting or fecesenriched soil, sewers, polluted fresh water and saltwater habitats.70-73 S. apiospermum has been isolated
preferentially from urban parks, playgrounds and other
developed areas compared to natural areas,74 including
from old decorative bark beneath a home dryer vent
in suburban Milwaukee County, Wisconsin.75 Other
examples include Rhizopus and Mucor spp. (sinus,
pulmonary, gastrointestinal and wound infections).
Transmissions of these fungi typically occur via
sporagiospores in outdoor or indoor air that is inhaled or
alighted on open wounds. Victims are usually diabetics
or immunocompromised.76,77
Fungal Disorders Primarily Acquired Indoors
The problem of indoor household mold has been an area
of active research and controversy the past three decades.
Some of this has been fueled by lawsuits and media
reports on “toxic mold” and “sick building syndrome.”
It is difficult to prove cause and effect for these health
conditions. Summaries of initial literature on this subject
suggest some of these concerns were founded and others
not. There is no general dose-response relationship
between fungal concentrations and specific human
disease.17,21,24 Furthermore, fungal species detection and
enumeration is dependent on the type of sampling and
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analytic technique used (quantitative polymerase chain
reaction may be the most useful to identify associations
between particular fungi and disease).78

however, some studies in human cells and nasal passages
are contradictory. β-glucans have been shown to be both
proinflammatory and anti-inflammatory.80

Respiratory Tract Illnesses: Relatively noncontroversial
diseases caused by indoor molds include allergic
bronchopulmonary aspergillosis (ABPA), allergic
sinusitis, and hypersensitivity pneumonitis. Clinical
allergic disease due to molds occurs in about 5% of the
total population, and these fungal allergies usually occur
in patients with a history of atopy (about 40% of the U.S.
population). The most common allergenic indoor molds
are Penicillium and Aspergillus. Cladosporium and
Alternaria are predominately outdoor molds commonly
found in indoor air and may provoke allergy.17,21,22
Allergic symptoms are often more prevalent in people
living in damp residences.17 Humidity and warmer
indoor air promote the growth of both mold (Figure
2) and house dust mites (a common allergen). Molds
also serve as food for Dermatophagoides dust mites,
further complicating the assignment of allergic etiologic
factors.21

Fungal hypersensitivity pneumonitis results from
an exaggerated normal immunoglobulin G immune
response to inhaled fungal proteins in conjunction
with inhalation of a very large quantity of such fungal
proteins. The interaction between the inhaled proteins
and the fungus-directed, cell-mediated antibody reaction
leads to an intense local immune response manifested
as chronic pneumonitis of the peripheral airways and
interstitium. Hypersensitivity pneumonitis has been
linked to humidifiers and HVAC systems (most cases are
occupational in origin). Humidifier exposures are more
often due to filamentous bacteria rather than fungi.21,22

The role of the fungal cell wall components, chitin
and β-glucans in allergy is unclear. Human studies
are limited.17,79 Smaller chitin fragments appear to
be protective of allergic responses in animal models,

Figure 2. Unidentified mold growing on a household

windowsill in Milwaukee County, Wisconsin, in the month
of February. This is a common occurrence in winter in the
upper Midwest due to condensation at the window interface
between warmer, moist indoor air and very cold outdoor air.
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Previous literature has associated indoor fungal
exposure with more respiratory tract illnesses in infants
and children17 and with increased asthma occurrence
and severity (as well as subsequent improvement after
household mold remediation).81 More recent studies
applying the environmental relative moldiness index
(ERMI) to homes have shown an association between
higher ERMI score and severe asthma versus no asthma
(but not versus moderate asthma) in household children
in Detroit,82 and between the ERMI and later respiratory
illnesses in atopic infants born in the Cincinnati area.83
The summation of levels of three molds (two Aspergillus
species and one Penicillium) was significantly associated
with the development of asthma at age 7 years in infants
from this same area who were studied, along with their
homes, beginning at age 1 year.84 This same authorship
group subsequently noted that the home characteristics of
air conditioning (negatively), carpeting (negatively), age
of home (positively) and dust mite allergen (positively)
were associated with the ERMI. Several variables were
confounded, and multivariate analysis suggested that
lower overall socioeconomic status was associated with
higher ERMI.85 Similar associations of certain indoor
molds with asthma and allergic symptoms (particularly
when mold odor was present) were found in single
studies and meta-analyses from other Midwestern and
worldwide locations.85-92
Toxic and Irritant Effects: Controversial concerns
regarding indoor molds are especially focused around
toxic effects. The major concerns are: 1) mycotoxins,
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which are relatively large, generally nonvolatile
molecules (i.e. require inhalation of aerosols of fungal
fragments, spores or large molecules) that are not
required for fungus growth or survival but often assist
in microbial competition; and 2) volatile organic
compounds (VOCs) released by molds. The latter is
responsible for the characteristic moldy odor. In the
United States, acute mold poisonings are uncommon
and mostly result from eating mold-contaminated
food or by acute inhalations of high concentrations of
mold particles or mycotoxins as part of agricultural or
other occupational exposure. Indoor residential mold
toxicity appears to be much less common and poorly
documented.17,21-23 Mycotoxins may persist long after
fungal particles are nonviable and may only become
a problem when dusts are formed. In addition, there
are numerous toxins and a poor understanding of their
genetic control and potential effects. Thus, it is difficult
to relate most toxins to specific symptoms.22

assessing mycotoxin levels in homes and lack of other
supporting evidence,21,22,24 although some investigators
remain more favorable toward this epidemiologic
association.93

There has been particular interest in the trichothecene
mycotoxins of Stachybotrys chartarum and its related
species since a mid-1990s outbreak of acute pulmonary
hemorrhage in Cleveland, Ohio, infants was initially
associated with this fungus.21,93 While Stachybotrys
spp. have been isolated from other substrates, including
gypsum (drywall), fiberglass wallpaper and aluminum
foil, it has an affinity for water-damaged cellulose.
However, this latter substance also promotes the
growth of Cladosporium, Penicillium and Aspergillus.
In nutrient-poor, damp-cellulose environments,
Stachybotrys is a tertiary colonizer following the
primary (Penicillium and Aspergillus versicolor) and
secondary (Cladosporium) fungal inhabitants. This fact
alone makes association of Stachybotrys with human
disease difficult,24 and many other molds are capable
of producing mycotoxins.21 The presence of toxigenic
molds in a household does not prove the presence of
mycotoxins or that the occupants were exposed to a
toxic dose.22 Recently it has been proposed that molds
from water-damaged buildings may reside internally
only in biofilms, likely in the sinuses. These molds
may continue to release and produce mycotoxins that
contribute to ongoing illness.94

Sick building syndrome is a controversial concept
defined as nonspecific symptoms of the eyes, skin
and upper airways, headaches and fatigue of uncertain
cause, all of which the patient associates with the
indoor environment (though not necessarily fungi). It
is more common among women and those with selfreported allergy or with certain personality traits such
as somatization and neuroticism.79 There is substantial
overlap of this concept and other controversial fungusrelated concerns discussed earlier.

Within 10 years of the Cleveland outbreak, considerable
doubt had been placed on the likelihood of Stachybotrys
toxicity due to serious methodological flaws, difficulty
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Fungal VOCs may cause direct surface irritation that
manifests as a burning sensation of the skin, eyes
and upper airways. These compounds also have been
suggested to cause symptoms such as lethargy and
headache, but these effects have not been confirmed
by controlled studies. It is more difficult to explain
other symptoms such as dizziness, memory loss,
gastrointestinal symptoms and muscle cramps.
The contribution to these symptoms of potential
psychological responses to VOCs notwithstanding,
there is little scientific evidence for VOC causality. As
with many fungal diseases, individual differences in
susceptibility may lead to discordant symptom histories
from equally exposed persons.17

Fungal Disease Acquired in all Residential
Settings
Aspergillosis: Conditions caused by Aspergillus
may occur from indoor or outdoor exposures,
be acute or chronic and have allergic or toxinmediated manifestations. Most infections occur
in immunocompromised patients, usually due to
Aspergillus fumigatus, and include invasive pulmonary
aspergillosis (cough, dyspnea with or without fever,
chest pain, hemoptysis, wheezing –– symptoms often
confused with other entities), pulmonary or sinus fungus
balls, chronic pulmonary aspergillosis, allergic fungal
sinusitis, invasive sinusitis, posttraumatic keratitis,
otomycosis (benign growth on external auditory
canal debris), endocarditis and other local, superficial
or disseminated forms.95,96 Which manifestation of
Aspergillus-related disease occurs, if any, following
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exposure depends upon the quantity and virulence of
the encountered strain and the host response.97
Forms of chronic pulmonary aspergillosis (e.g. simple
aspergilloma, chronic cavitary pulmonary aspergillosis,
chronic necrotizing pulmonary aspergillosis) are
uncommon and nearly always occur in those with
underlying chronic obstructive pulmonary disease,
diabetes or other immunosuppressive states. Patients
usually present with chronic relapsing cough, dyspnea
and weight loss. Chest pain, fatigue, fever and acute
hemoptysis also may occur.98
Allergic bronchopulmonary aspergillosis is a pulmonary
manifestation of allergy to A. fumigatus in rural and
urban asthmatics that may start in childhood and remain
unrecognized for years (some advocate screening
all asthmatics for ABPA). The process begins with
sensitization in an asthmatic who remains in good control
but may progress to steroid-dependent asthma, then to
end-stage fibrotic pulmonary disease and “honeycomb
lung.” Some patients experience a prolonged remission.
Aspergillus allergic disease also complicates cystic fibrosis,
but laboratory and clinical features are distinct.96,97
Most infections occur following inhalation of conidia.
Aspergillus is ubiquitous in air, and sources of spores
include soil, decaying vegetation and dust. The relative
importance of soil as a source of infection compared
to plants, flowers, building materials, water and other
environments is unclear.11,99 Aspergillus fungi were
commonly isolated from refrigerator surfaces and foods,
pillows,20 laundered socks,100 composted wood chips
and yard waste.96 Sputum isolations of A. fumigatis have
been associated with higher levels of the fungus in the
air inside patient homes (although correlation with A.
fumigates sensitization was not demonstrated).101
Fusariam: Fusarium spp. may cause many of the
nonallergic manifestations seen with Aspergillus,
frequently in immunocompromised persons. Fusarium is
found worldwide in soil, water, decaying organic debris
and on plants and is spread by air or rain. Infection, and
perhaps hypersensitivity pneumonitis, may be acquired
at home.102,103
Black Fungi: Phaeohyphomycosis is a term applied
to clinical syndromes caused by fungi containing
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high levels of melanin, exclusive of eumycetoma and
chromoblastomycosis. Diseases that characterize
phaeohyphomycosis include allergic fungal sinusitis
and allergic bronchopulmonary mycosis similar
to that of Aspergillus, superficial infections (often
starting as a single inflammatory cyst on an extremity),
deep local infections (often related to trauma or
immunosuppression), disseminated infections (usually
in the immunocompromised), pulmonary disease
(usually in immunocompromised patients or those with
underlying lung disease) and central nervous system
infection (often in normal hosts). Melanin appears to
be a virulence factor in complex, multifactorial and
incompletely understood ways.104-106
A variety of genera may be agents of phaeohyphomycosis.
Three examples are given here. Alternaria and
Cladosporium are ubiquitous fungi commonly found
in outdoor and indoor air. Both may cause chronic
allergic sinusitis in normal hosts. The former has caused
ulcerated cutaneous infections, visceral infections,
osteomyelitis, keratitis, onychomycosis and invasive
sinusitis in immunocompromised individuals, especially
those with bone marrow transplants. The latter rarely
causes similar disease and pulmonary infections.104,105
Exophiala (black yeasts) may cause a variety of deep
and cutaneous infections, sinusitis and rare other entities
in normal and immunocompromised hosts.104,105,107
Infections by these fungi may be underdiagnosed in the
United States.107 They may be found in water, soil, plants
and decaying woody material. Indoors, Exophiala may
be identified in dishwashers,13 sink drains, bathwater,12
and other bathroom and shower surfaces (along with
Cladosporium).108 Infection by Exophiala occurs by
traumatic inoculation and rarely by inhalation.105
Prevention
A recent commentary from the Centers for Disease
Control and Prevention pointed out that “fungal
infections remain serious and underappreciated
causes of illness and death.”109 Prevention of sequelae
from these infections includes clinician and public
awareness.
Immunocompromised patients should be especially
warned regarding risks for fungal infection and ways to
prevent fungal exposure. In the domestic environment,
this would include maintaining proper personal skin
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integrity and hand hygiene before eating or handling
food, after going outdoors and after touching plants,
pets or soil. Household measures include keeping
water-exposed surfaces and areas of dust accumulation
cleaned and disinfected where appropriate, avoiding
standing water, using sterile water in nebulizers and
humidifiers, and removing water-damaged materials.
It is best to avoid home (or yard) renovation, attics,
crawl spaces, excavation, caves and musty areas
during immunosuppression.110 There is moderate
evidence that remediation of moldy houses reduces
asthma symptoms and respiratory infections,111 but
controlled trials regarding allergic rhinitis have been
few and nonconfirmatory.17,111 Mold spores are present
in all outdoor and indoor environments and cannot be
eliminated.22
General measures for all persons to reduce the risk
of domestically acquired fungal disease include
maintaining relative humidity below 60% and limiting
shower and pot-boiling times, the number of plants
to be watered and the use of exhaust fans. Cold
surfaces, such as windowsills in winter, promote mold
growth. Visible mold in the home should be removed,
with particular attention to the underlying cause of
excessive moisture. In particular, water leaks should
be remediated immediately, and proper HVAC system
maintenance ensured. Health departments are often
helpful in guiding home remediation. Commercial
mold remediation companies may be used if qualified
and ethical.17,21,22,110
Summary
A variety of fungal microorganisms are capable of
departing a soil environment and causing serious focal
or systemic infection in humans. Specific evolved
virulence factors for the ability to grow in diverse,
sometimes harsh, domestic microenvironments may
promote infection acquired on one’s personal property.
Although many of the fungal diseases listed in this
article are uncommon, they can occur in individuals
largely restricted to a domestic environment in the
Midwest. Delay in diagnosis from dismissing a disease
such as blastomycosis or failing to consider a fungal
etiology for a deep wound infection due to the apparent
lack of traditional outdoor recreational or occupational
risk factors may lead to patient morbidity or mortality. If
a home- or yard-related fungal infection is discovered,
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source investigation may be an important public health
measure. Similarly, in patients who present with
self-described mold-related illnesses, an appropriate
differential diagnosis should be followed and other
causes of the particular complaints ruled out.
Patient-Friendly Recap
• Myriad fungal spores live in Midwestern homes
and yards and can occasionally cause serious
infections in residents.
• The author reviewed more than 100 sources
to identify the most notable disease-causing
domestic fungi (excluding contaminated food or
toiletries) and related symptoms.
• Delay in diagnosis can be avoided if clinicians
learn to spot the signs of these often challenging
fungal infections.

Conflicts of Interest
None.
References

1. Robert VA, Casadevall A. Vertebrate endothermy restricts most
fungi as potential pathogens. J Infect Dis. 2009;200:1623-6.
CrossRef
2. Casadevall A. Fungal virulence, vertebrate endothermy, and
dinosaur extinction: is there a connection? Fungal Genet Biol.
2005;42:98-106. CrossRef
3. Warren CPW. Overview of respiratory health risks in
agriculture. In: Dosman JA, Cockcroft DW (eds). Principles
of Health and Safety in Agriculture. Boca Raton, FL: CRC
Press, 1989, pp. 47-9.
4. Maier RM, Pepper IL, Gerba CP (eds). Environmental
Microbiology, Second Edition. Burlington, MA: Elsevier
Academic Press, 2009, pp. 70-80, 357-63, 445-7.
5. Voroney RP. The soil habitat. In: Paul EA (ed). Soil
Microbiology, Ecology and Biochemistry, Third Edition.
Burlington, MA: Elsevier Academic Press, 2007, pp. 25-49.
6. Weinberg ED. The influence of soil on infectious disease.
Experientia. 1987;43:81-7. CrossRef
7. Barton LL, Northrup DE. Microbial Ecology. Hoboken, NJ:
Wiley-Blackwell, 2011, pp. 111-7.
8. Berg G, Eberl L, Hartmann A. The rhizosphere as a reservoir
for opportunistic human pathogenic bacteria. Environ
Microbiol. 2005;7:1673-85. CrossRef
9. Baumgardner DJ. Soil-related bacterial and fungal infections.
J Am Board Fam Med. 2012;25:734-44. CrossRef
10. Cooney NM, Klein BS. Fungal adaptation to the mammalian
host: it’s a new world, after all. Curr Opin Microbiol.
2008;11:511-6. CrossRef
11. Bennett JW. Aspergillus: a primer for the novice. Med Mycol.
2009;47 Suppl 1:S5-12. CrossRef

www.aurora.org/jpcrr

107

12. Gostinčar C, Grube M, Gunde-Cimerman N. Evolution of
fungal pathogens in domestic environments? Fungal Biol.
2011;115:1008-18. CrossRef
13. Zalar P, Novak M, de Hoog GS, Gunde-Cimerman N.
Dishwashers – a man-made ecological niche accommodating
human opportunistic fungal pathogens. Fungal Biol.
2011;115:997-1007. CrossRef
14. Gostinčar C, Grube M, de Hoog S, Zalar P, Gunde-Cimerman
N. Extremotolerance in fungi: evolution on the edge. FEMS
Microbiol Ecol. 2010;71:2-11. CrossRef
15. Baumgardner DJ. Microecology of Blastomyces dermatitidis:
the ammonia hypothesis. Med Mycol. 2009;47:745-52.
CrossRef
16. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick
T, Ghannoum MA. Biofilm formation by the fungal pathogen
Candida albicans: development, architecture, and drug
resistance. J Bacteriol. 2001;183:5385-94. CrossRef
17. Portnoy JM, Kwak K, Dowling P, VanOsdol T, Barnes C.
Health effects of indoor fungi. Ann Allergy Asthma Immunol.
2005;94:313-20. CrossRef
18. Miranda ML, Galeano MAO, Hale B, Thomann WR. Crawl
spaces as reservoirs for transmission of mold to the livable
part of the home environment. Rev Environ Health. 2011;26:
205-13.
19. Adams RI, Miletto M, Taylor JW, Bruns TD. The diversity
and distribution of fungi on residential surfaces. PLoS One.
2013;8:e78866. CrossRef
20. Woodcock AA, Steel N, Moore CB, Howard SJ, Custovic
A, Denning DW. Fungal contamination of bedding. Allergy.
2006;61:140-2. CrossRef
21. Chapman JA, Terr AI, Jacobs RL, Charlesworth EN, Bardana
EJ Jr. Toxic mold: phantom risk vs science. Ann Allergy
Asthma Immunol. 2003;91:222-32. CrossRef
22. Hardin BD, Kelman BJ, Saxon A. Adverse human health
effects associated with molds in the indoor environment. J
Occup Environ Med. 2003;45:470-8.
23. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev.
2003;16:497-516. CrossRef
24. Khun DM, Ghannoum MA. Indoor mold, toxigenic fungi, and
Stachybotrys chartarum: infectious disease perspective. Clin
Microbiol Rev. 2003;16:144-72. CrossRef
25. Benedict K, Park BJ. Invasive fungal infections after natural
disasters. Emerg Infect Dis. 2014;20:349-55. CrossRef
26. Flynn NM, Hoeprich PD, Kawachi MM, et al. An unusual
outbreak of windborne coccidioidomycosis. N Engl J Med.
1979;301:358-61. CrossRef
27. Deepe GS Jr. Histoplasma capsulatum (Histoplasmosis). In:
Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas,
and Bennett’s Principles and Practice of Infectious Diseases,
Eighth Edition. Philadelphia: Elsevier Saunders, 2015, pp.
2949-62.e1.
28. Baumgardner DJ, Burdick JS. An outbreak of human and canine
blastomycosis. Rev Infect Dis. 1991;13:898-905. CrossRef
29. Kitchen MS, Reiber CD, Eastin GB. An urban epidemic
of North American blastomycosis. Am Rev Respir Dis.
1977;115:1063-6.
30. Cano MV, Hajjeh RA. The epidemiology of histoplasmosis: a
review. Semin Resp Infect. 2001;16:109-18. CrossRef
31. Neblett Fanfair R, Benedict K, Bos J, et al. Necrotizing
cutaneous mucormycosis after a tornado in Joplin, Missouri,
in 2011. N Engl J Med. 2012;367:2214-25. CrossRef

108 JPCRR • Volume 3, Issue 2 • Spring 2016

32. Reiss E, Shadomy HJ, Lyon GM III. Histoplasmosis. In:
Fundamental Medical Mycology. Hoboken, NJ: WileyBlackwell, 2012, pp. 165-86.
33. Heymann DL (ed). Histoplasmosis. In: Control of
Communicable Diseases Manual, 19th Edition. Washington,
DC: American Public Health Association, 2008, pp. 305-8.
34. Wheat LJ. Approach to the diagnosis of the endemic mycoses.
Clin Chest Med. 2009;30:379-89. CrossRef
35. Lockwood GF, Garrison RG. The possible role of uric acid
in the ecology of Histoplasma capsulatum. Mycopathol Mycol
Appl. 1968;35:377-88. CrossRef
36. Schlech WF 3rd, Wheat JL, Ho JL, et al. Recurrent urban
histoplasmosis, Indianapolis, Indiana, 1980-1981. Am J
Epidemiol. 1983;118:301-12.
37. Bartlett PC, Vonbehren LA, Tewari RP, et al. Bats in the
belfry: an outbreak of histoplasmosis. Am J Public Health.
1982;72:1369-72. CrossRef
38. Taylor ML, Ruiz-Palacios GM, del Rocío Reyes-Montes M, et al.
Identification of the infectious source of an unusual outbreak
of histoplasmosis, in a hotel in Acapulco, state of Guerrero,
Mexico. FEMS Immunol Med Microbiol. 2005;45:435-41.
CrossRef
39. Chick EW, Compton SB, Pass T 3rd, et al. Hitchcock’s
birds, or the increased rate of exposure to Histoplasma from
blackbird roost sites. Chest. 1981;80:434-8. CrossRef
40. Centers for Disease Control and Prevention (CDC).
Histoplasmosis outbreak associated with the renovation of
an old house – Quebec, Canada, 2013. MMWR Morb Mortal
Wkly Rep. 2014;62:1041-4.
41. Fuortes L, Hayes T. An outbreak of acute histoplasmosis in a
family. Am Fam Physician. 1988;37:128-32.
42. Byrd RB, Leavey R, Trunk G. The Chanute histoplasmosis
epidemic: new variations of urban histoplasmosis. Chest.
1975;6:791-5. CrossRef
43. Bradsher RW Jr. Blastomycosis. In: Bennett JE, Dolin R, Blaser
MJ (eds). Mandell, Douglas, and Bennett’s Principles and
Practice of Infectious Diseases, Eighth Edition. Philadelphia:
Elsevier Saunders, 2015, pp. 2963-73.e2.
44. Baumgardner DJ. Blastomycosis. In: Domino FJ, Baldor
RA, Golding J, Grimes JA (eds). 5-Minute Clinical Consult
2015, 23rd edition. Philadelphia, PA: Wolters Kluwer
Health, 2014 (available online at: https://5minuteconsult.
com/collectioncontent/1-151452/diseases-and-conditions/
blastomycosis).
45. Baumgardner DJ, Temte JL, Gutowski E, et al. The differential
diagnosis of pulmonary blastomycosis using case vignettes:
a Wisconsin Network for Health Research (WiNHR) study.
WMJ. 2011;110:68-73.
46. Brown EM, McTaggart LR, Zhang SX, et al. Phylogenetic
analysis reveals a cryptic species Blastomyces gilchristii,
sp. nov. within the human pathogenic fungus Blastomyces
dermatitidis. PLoS One. 2013;8:e59237. CrossRef
47. Baumgardner DJ, Paretsky DP. The in vitro isolation of
Blastomyces dermatitidis from a woodpile in north central
Wisconsin, USA. Med Mycol. 1999;37:163-8. CrossRef
48. Baumgardner DJ, Laundre B. Studies on the molecular ecology of
Blastomyces dermatitidis. Mycopathologia. 2000;152:51-8.
CrossRef
49. Baumgardner DJ, Paretsky DP, Baeseman ZJ, Schreiber
A. Effects of season and weather on blastomycosis in dogs:
Northern Wisconsin, USA. Med Mycol. 2011;49:49-55. CrossRef

Review

50. Baumgardner DJ, Bernhard KA, Egan G. Pulmonary
blastomycosis in Vilas County, Wisconsin: weather, exposures
and symptoms. J Patient Cent Res Rev. 2015;2:25-33. CrossRef
51. Baumgardner DJ, Summerbell R, Krajden S, et al. Attempted
isolation of Blastomyces dermatitidis from native shrews
in northern Wisconsin, USA. Med Mycol. 2005;43:413-6.
CrossRef
52. DiSalvo AF. The ecology of Blastomyces dermatitidis. In:
Al-Doory Y, DiSalvo AF (eds). Blastomycosis. New York:
Plenum, 1992, pp. 43-73.
53. Baumgardner DJ, Paretsky DP, Yopp AC. The epidemiology
of blastomycosis in dogs: north central Wisconsin, USA. J
Med Vet Mycol. 1995;33:171-6. CrossRef
54. Bachir J, Fitch GL. Northern Wisconsin married couple
infected with blastomycosis. WMJ. 2006;105:55-7.
55. Proctor RA. Infectious diseases in Wisconsin. WMJ.
1998;97:20-2.
56. Proctor RA. Blastomycosis is a serious disease, but let’s not
raise fears without conclusive data. WMJ. 2001;100:8-9, 34.
57. Blondin N, Baumgardner DJ, Moore GE, Glickman LT.
Blastomycosis in indoor cats: suburban Chicago, Illinois,
USA. Mycopathologia. 2007;163:59-66. CrossRef
58. Baumgardner DJ, Paretsky DP. Blastomycosis: more evidence
for exposure near one’s domicile. WMJ. 2001;100:43-5.
59. Lowry PW, Kelso KY, McFarland LM. Blastomycosis in
Washington Parish, Louisiana, 1976-1985. Am J Epidemiol.
1989;130:151-9.
60. Chapman SW, Lin AC, Hendricks KA, et al. Endemic
blastomycosis in Mississippi: epidemiological and clinic
studies. Semin Respir Infect. 1997;12:219-28.
61. Roy M, Benedict K, Deak E, et al. A large community outbreak
of blastomycosis in Wisconsin with geographic and ethnic
clustering. Clin Infect Dis. 2013;57:655-62. CrossRef
62. Denton JF, DiSalvo AF. Additional isolations of Blastomyces
dermatitidis from natural sites. Am J Trop Med Hyg.
1979;28:697-700.
63. Reiss E, Shadomy HJ, Lyon GM III. Sporotrichosis. In:
Fundamental Medical Mycology. Hoboken, NJ: WileyBlackwell, 2012, pp. 215-32.
64. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki
T, Li S. Global epidemiology of sporotrichosis. Med Mycol.
2015;53:3-14. CrossRef
65. de Meyer EM, de Beer ZW, Summerbell RC, et al. Taxonomy
and phylogeny of new wood- and soil-inhabiting Sporothrix
species in the Ophiostoma stenoceras-Sporothrix schenckii
complex. Mycologia. 2008;100:647-61. CrossRef
66. Centers for Disease Control (CDC). Multistate outbreak of
sporotrichosis in seedling handlers, 1988. MMWR Morb
Mortal Wkly Rep. 1988;37:652-3.
67. Dooley DP, Bostic PS, Beckius ML. Spook house
sporotrichosis: a point-source outbreak of sporotrichosis
associated with hay bale props in a Halloween haunted-house.
Arch Intern Med. 1997;157:1885-7. CrossRef
68. Mincher J, Baumgardner DJ. Sporotrichosis in eastern Wisconsin.
(abstr.) Wisconsin Health Improvement and Research Partnerships
Forum, Madison, WI (September 2011). http://www.fammed.wisc.
edu/files/webfm-uploads/documents/research/wren/2011forum/
posters/Jeff%20Mincher.doc. Accessed March 17, 2016.
69. Chen SC, Blyth CC, Sorrell TC, Slavin MA. Pneumonia and
lung infections due to emerging and unusual fungal pathogens.
Semin Resp Crit Care Med. 2011;32:703-16. CrossRef

Review

70. Rainer J, De Hoog GS. Molecular taxonomy and ecology
of Pseudallescheria, Petriella and Scedosporium prolificans
(Microascaceae) containing opportunistic agents on humans.
Mycol Res. 2006;110:151-60. CrossRef
71. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused
by Scedosporium spp. Clin Microbiol Rev. 2008;21:157-97.
CrossRef
72. Guarro J, Kantarcioglu AS, Horré R, et al. Scedosporium
apiospermum: changing clinical spectrum of a therapyrefractory opportunist. Med Mycol. 2006;44:295-327.
CrossRef
73. de Hoog GS, Marvin-Sikkema FD, Lahpoor GA, Gottschall
JC, Prins RA, Guého E. Ecology and physiology of the
emerging opportunistic fungi Pseudallescheria boydii and
Scedosporium prolificans. Mycoses. 1994;37:71-8. CrossRef
74. Kaltseis J, Rainer J, De Hoog GS. Ecology of Pseudallescheria
and Scedosporium species in their human-dominated and
natural environments and their distribution in clinical samples.
Med Mycol. 2009;47:398-405. CrossRef
75. Baumgardner DJ, Chaturvedi S, Li X. My Chrysosporium is
a Scedosporium. (abstr.) J Patient Cent Res Rev. 2014;1:48-9.
CrossRef
76. Vainrub B, Macareno A, Mandel S, Musher DM. Wound
zygomycosis (mucormycosis) in otherwise healthy adults. Am
J Med. 1988;84:546-8. CrossRef
77. Reiss E, Shadomy HJ, Lyon GM III. Mucormycosis. In:
Fundamental Medical Mycology. Hoboken, NJ: WileyBlackwell, 2012, pp. 431-55.
78. Méheust D, Le Cann P, Reboux G, Millon L, Gangneux JP.
Indoor fungal contamination: health risks and measurement
methods in hospitals, homes and workplaces. Crit Rev
Microbiol. 2014;40:248-60. CrossRef
79. Norbäck D. An update on sick building syndrome. Curr Opin
Allergy Clin Immunol. 2009;9:55-9. CrossRef
80. Catalli A, Kulka M. Chitin and β-glucan polysaccharides
as immunomodulators of airway inflammation and atopic
disease. Recent Pat Endocr Metab Immune Drug Discov.
2010;4:175-89. CrossRef
81. Jaakkola MS, Jaakkola JJ. Indoor molds and asthma in adults.
Adv Appl Microbiol. 2004;55:309-38. CrossRef
82. Vesper S, McKinstry C, Haugland R, et al. Higher
Environmental Relative Moldiness Index (ERMIsm) values
measured in Detroit homes of severely asthmatic children. Sci
Total Environ. 2008;394:192-6. CrossRef
83. Vesper SJ, McKinstry C, Haugland RA, et al. Relative
moldiness index as predictor of childhood respiratory illness.
J Expo Sci Environ Epidemiol. 2007;17:88-94. CrossRef
84. Reponen T, Lockey J, Bernstein DI, et al. Infant origins of
childhood asthma associated with specific molds. J Allergy
Clin Immunol. 2012;130:639-44.e5. CrossRef
85. Reponen T, Levin L, Zheng S, et al. Family and home
characteristics correlate with mold in homes. Environ Res.
2013;124:67-70. CrossRef
86. Meng J, Barnes CS, Rosenwasser LJ; Children’s Mercy Center
for Environmental Health. Identity of the fungal species
present in the homes of asthmatic children. Clin Exp Allergy.
212;42:1448-58. CrossRef
87. Vesper S, Barnes C, Ciaccio CE, et al. Higher Environmental
Relative Moldiness Index (ERMI) values measured in homes
of asthmatic children in Boston, Kansas City, and San Diego.
J Asthma. 2013;50:155-61. CrossRef

www.aurora.org/jpcrr

109

88. Bundy KW, Gent JF, Beckett W, et al. Household airborne
Penicillium associated with peak expiratory flow variability
in asthmatic children. Ann Allergy Asthma Immunol.
2009;103:26-30. CrossRef
89. Jaakkola MS, Quansah R, Hugg TT, Heikkinen SA, Jaakkola
JJ. Association of indoor dampness and molds with rhinitis
risk: a systematic review and meta-analysis. J Allergy Clin
Immunol. 2013;132:1099-110.e18. CrossRef
90. Quansah R, Jaakkola MS, Hugg TT, Heikkinen SA, Jaakkola
JJ. Residential dampness and molds and the risk of developing
asthma: a systematic review and meta-analysis. PLoS One.
2012;7:e47526. CrossRef
91. Tischer C, Chen CM, Heinrich J. Association between domestic
mould and mould components, and asthma and allergy in children:
a systematic review. Eur Respir J. 2011;38:812-24. CrossRef
92. Shenassa ED, Daskalakis C, Liebhaber A, Braubach M,
Brown MJ. Dampness and mold in the home and depression:
an examination of mold-related illness and perceived control
of one’s home as possible depression pathways. Am J Public
Health. 2007;97:1893-9. CrossRef
93. Etzel RA. Stachybotrys. Curr Opin Pediatr. 2003;15:103-6.
CrossRef
94. Brewer JH, Thrasher JD, Hooper D. Chronic illness associated
with mold and mycotoxins: is naso-sinus fungal biofilm the
culprit? Toxins (Basel). 2014;6:66-80. CrossRef
95. Boucher HW, Patterson TF. Aspergillosis. In: Hospenthal DR,
Rinaldi MG (eds). Diagnosis and Treatment of Human Mycoses.
Totowa, NJ: Humana Press, 2008, pp.181-99. CrossRef
96. Reiss E, Shadomy HJ, Lyon GM III. Aspergillosis. In:
Fundamental Medical Mycology. Hoboken, NJ: WileyBlackwell, 2012, pp. 357-96.
97. Agarwal R, Chakrabarti A. Allergic bronchopulmonary
aspergillosis in asthma: epidemiological, clinical and therapeutic
issues. Future Microbiol. 2013;8:1463-74. CrossRef
98. Schweer KE, Bangard C, Hekmat K, Cornely OA. Chronic
pulmonary aspergillosis. Mycoses. 2014;57:257-70. CrossRef
99. Hajjeh RA, Warnock DW. Counterpoint: invasive aspergillosis
and the environment – rethinking our approach to prevention.
Clin Infect Dis. 2001;33:1549-52. CrossRef
100. Amichai B, Grunwald MH, Davidovici B, Farhi R, Shemer A.
The effect of domestic laundry processes on fungal contamination
of socks. Int J Dermatol. 2013;52:1392-4. CrossRef

110

JPCRR • Volume 3, Issue 2 • Spring 2016

101. Fairs A, Agbetile J, Bourne M, et al. Isolation of Aspergillus
fumigatus from sputum is associated with elevated airborne
levels in homes of patients with asthma. Indoor Air.
2013;23:275-84. CrossRef
102. Gorman SR, Magiorakos AP, Zimmerman SK, Craven DE.
Fusarium oxysporum pneumonia in an immunocompetent
host. South Med J. 2006;99:613-6. CrossRef
103. Lee SK, Kim SS, Nahm DH, et al. Hypersensitivity
pneumonitis caused by Fusarium napiforme in a home
environment. Allergy. 2000;55:1190-3. CrossRef
104. Revankar SG, Sutton DA. Melanized fungi in human disease.
Clin Microbiol Rev. 2010;23:884-928. CrossRef
105. Reiss E, Shadomy HJ, Lyon GM III. Phaeohyphomycosis.
In: Fundamental Medical Mycology. Hoboken, NJ: WileyBlackwell, 2012, pp. 493-511.
106. Garnica M, Nucci M, Queiroz-Telles F. Difficult
mycoses of the skin: advances in the epidemiology and
management of eumycetoma, phaeohyphomycosis and
chromoblastomycosis. Curr Opin Infect Dis. 2009;22:
559-63. CrossRef
107. Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak
MJ, de Hoog GS. Spectrum of clinically relevant Exophiala
species in the United States. J Clin Microbiol. 2007;45:
3713-20. CrossRef
108. Lian X, de Hoog GS. Indoor wet cells harbour melanized
agents of cutaneous infection. Med Mycol. 2010;48:622-8.
CrossRef
109. Brandt ME, Park BJ. Think fungus – prevention and control
of fungal infections. Emerg Infect Dis. 2013;19:1688-9.
CrossRef
110. Smith CM, Kagan SH. Prevention of systemic mycoses
by reducing exposure to fungal pathogens in hospitalized
and ambulatory neutropenic patients. Oncol Nurs Forum.
2005;32:565-79. CrossRef
111. Sauni R, Uitti J, Jauhiainen M, Kreiss K, Sigsgaard T, Verbeek
JH. Remediating buildings damaged by dampness and mould
for preventing or reducing respiratory tract symptoms,
infections and asthma (Review). Evid Based Child Health.
2013;8:944-1000. CrossRef
© 2016 Aurora Health Care, Inc.

Review

